$5.60
▼ $0.08 (-1.3%)
LEXX
Lexaria Bioscience Corp.
Health Care
Investor Score
34F
Weak rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
15
Technical
35
Fundamental
40
Growth
38
Fair Value
50
News
42
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.